By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Hogehilweg 7
1101 CA
Amsterdam Zuid-Oost      The Netherlands
Phone: 31-20-567-0900 Fax: 31-20-567-0999



Company News
Access Pharmaceuticals (ACCP) Announces European License Agreement With Norgine 8/7/2014 7:50:59 AM
Norgine Release: New Data Show How Hepatic Encephalopathy Contributes To Burden Of Liver Disease 4/11/2014 9:59:24 AM
Altacor Strengthens Commercial Capability With Norgine Collaboration - for the Promotion of Altacor's Dry Eye Product Clinitas® in the UK 7/1/2013 11:01:56 AM
Norgine Release: PBAC Approves XIFAXAN® (Rifaxamin a) 550 mg Cost Effectiveness in Australia 5/28/2013 9:07:39 AM
Tranzyme Pharma (TZYM)/Norgine GI Drug Fails Second Late-stage Trial 5/28/2012 11:17:24 PM
Tranzyme Pharma (TZYM) and Norgine Bowel Drug Fails Trial 3/12/2012 6:58:33 AM
Tranzyme Pharma and Norgine Complete Enrollment in ULISES 008, the Second of Two Phase 3 Pivotal Trials of Ulimorelin 2/28/2012 9:35:14 AM
APR Applied Pharma Research S.A., Labtec GmbH and Norgine Announce the Signature of an Exclusive Licensing Agreement Under Which Norgine will Market and Distribute Setofilmâ„¢ 1/18/2012 6:18:01 AM
Pharma Firm Norgine Plans 36 Job Losses 1/6/2012 8:12:30 AM
Tranzyme Pharma and Norgine Complete Enrollment in First of Two Pivotal Phase 3 Trials of Ulimorelin 12/7/2011 9:50:06 AM